Operator
Welcome to at the moment’s MiMedx investor convention name. [Operator Instructions] As a reminder, this convention is being recorded. I might now like to show the convention over to your host, Mr. Matt Notarianni, Head of Investor Relations for MiMedx. Thanks. You could start.
Matthew Notarianni
Head of Investor Relations
Thanks, operator, and good afternoon, everybody. We’re excited to welcome you to at the moment’s convention name the place we’ll focus on our just lately introduced plans to accumulate Sanara MedTech in addition to MiMedx’s second quarter 2026 working and monetary outcomes.
With me on at the moment’s name are Chief Govt Officer Joe Capper and Chief Monetary Officer Doug Rice. As a part of at the moment’s webcast, we’re concurrently displaying slides which you could observe. You’ll be able to entry the slides from the Investor Relations web site at mimedx.com.
Joe will kick us off with some opening remarks in regards to the Sanara transaction earlier than we proceed with the abstract of our second quarter 2026 working and monetary outcomes highlights. And Doug will present an in depth overview of our outcomes for the quarter, after which we’ll conclude with some extra updates earlier than we open the road in your questions.
Earlier than we start, I want to remind you that our feedback at the moment will embody forward-looking statements, together with statements concerning future gross sales, working outcomes and money steadiness development, future margins and bills, our product portfolios, anticipated market sizes for our merchandise
